ACS Publications. Most Trusted. Most Cited. Most Read
Experimental Evolution of Diverse Strains as a Method for the Determination of Biochemical Mechanisms of Action for Novel Pyrrolizidinone Antibiotics
My Activity
    Article

    Experimental Evolution of Diverse Strains as a Method for the Determination of Biochemical Mechanisms of Action for Novel Pyrrolizidinone Antibiotics
    Click to copy article linkArticle link copied!

    View Author Information
    Department of BioSciences, Rice University, 6100 Main Street, Houston, Texas 77005, United States
    Department of Chemistry, BioScience Research Collaborative, Rice University, 6100 Main Street, Houston, Texas 77005, United States
    Other Access OptionsSupporting Information (1)

    ACS Infectious Diseases

    Cite this: ACS Infect. Dis. 2017, 3, 11, 854–865
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsinfecdis.7b00135
    Published September 23, 2017
    Copyright © 2017 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    The continuing rise of multidrug resistant pathogens has made it clear that in the absence of new antibiotics we are moving toward a “postantibiotic” world, in which even routine infections will become increasingly untreatable. There is a clear need for the development of new antibiotics with truly novel mechanisms of action to combat multidrug resistant pathogens. Experimental evolution to resistance can be a useful tactic for the characterization of the biochemical mechanism of action for antibiotics of interest. Herein, we demonstrate that the use of a diverse panel of strains with well-annotated reference genomes improves the success of using experimental evolution to characterize the mechanism of action of a novel pyrrolizidinone antibiotic analog. Importantly, we used experimental evolution under conditions that favor strongly polymorphic populations to adapt a panel of three substantially different Gram-positive species (lab strain Bacillus subtilis and clinical strains methicillin-resistant Staphylococcus aureus MRSA131 and Enterococcus faecalis S613) to produce a sufficiently diverse set of evolutionary outcomes. Comparative whole genome sequencing (WGS) between the susceptible starting strain and the resistant strains was then used to identify the genetic changes within each species in response to the pyrrolizidinone. Taken together, the adaptive response across a range of organisms allowed us to develop a readily testable hypothesis for the mechanism of action of the CJ-16 264 analog. In conjunction with mitochondrial inhibition studies, we were able to elucidate that this novel pyrrolizidinone antibiotic is an electron transport chain (ETC) inhibitor. By studying evolution to resistance in a panel of different species of bacteria, we have developed an enhanced method for the characterization of new lead compounds for the discovery of new mechanisms of action.

    Copyright © 2017 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsinfecdis.7b00135.

    • Figure S1, killing curves for pyrrolizidinone natural product (CJ-16,264) and analog (KCN-AAS-35) against S. aureus MRSA131; Figure S2, growth of B. subtilis D11-1 and G11-2; Table S1, mutations identified in KCN-AAS-35 adapted clones (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 5 publications.

    1. Seokju Seo, Saoirse Disney-McKeethen, Ramya Ganiga Prabhakar, Xinhao Song, Heer H. Mehta, Yousif Shamoo. Identification of Evolutionary Trajectories Associated with Antimicrobial Resistance Using Microfluidics. ACS Infectious Diseases 2022, 8 (1) , 242-254. https://doi.org/10.1021/acsinfecdis.1c00564
    2. K. C. Nicolaou, Kiran Kumar Pulukuri, Stephan Rigol, Marek Buchman, Akshay A. Shah, Nicholas Cen, Megan D. McCurry, Kathryn Beabout, and Yousif Shamoo . Enantioselective Total Synthesis of Antibiotic CJ-16,264, Synthesis and Biological Evaluation of Designed Analogues, and Discovery of Highly Potent and Simpler Antibacterial Agents. Journal of the American Chemical Society 2017, 139 (44) , 15868-15877. https://doi.org/10.1021/jacs.7b08749
    3. Seokju Seo, Ramya Ganiga Prabhakar, Saoirse Disney-McKeethen, Xinhao Song, Yousif Shamoo. Microfluidic platform for spatially segregated experimental evolution studies with E. coli. STAR Protocols 2022, 3 (2) , 101332. https://doi.org/10.1016/j.xpro.2022.101332
    4. Nicholas A. Hummell, Alexey V. Revtovich, Natalia V. Kirienko, . Novel Immune Modulators Enhance Caenorhabditis elegans Resistance to Multiple Pathogens. mSphere 2021, 6 (1) https://doi.org/10.1128/mSphere.00950-20
    5. Nicholas A. Hummell, Natalia V. Kirienko. Repurposing bioactive compounds for treating multidrug-resistant pathogens. Journal of Medical Microbiology 2020, 69 (6) , 881-894. https://doi.org/10.1099/jmm.0.001172

    ACS Infectious Diseases

    Cite this: ACS Infect. Dis. 2017, 3, 11, 854–865
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsinfecdis.7b00135
    Published September 23, 2017
    Copyright © 2017 American Chemical Society

    Article Views

    736

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.